Perioperative chemotherapy with cisplatin (CP) and doxorubicin (DOX) with and without high-dose methotrexate (HDM) in adult osteosarcoma (AOT): Is methotrexate warranted?

被引：0
|
作者：
Da Silva Rocha, Lucila Soares [1 ]
Negrao, Marcelo Vailati [1 ]
Girardi, Daniel da Motta [1 ]
De Camargo, Veridiana Pires [1 ]
Valente Alban, Luciana Bastos [1 ]
Hoff, Paulo Marcelo [1 ]
Feher, Olavo [1 ]
机构：
[1] Inst Canc Estado Sao Paolo, Sao Paulo, SP, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10523
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible
    Anderson, Pete
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 624 - 625
  • [22] SFOPOS94:: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
    Le Deley, Marie-Cecile
    Guinebretiere, Jean-Marc
    Gentet, Jean-Claude
    Pacquement, Helene
    Pichon, Fabienne
    Marec-Berard, Perrine
    Entz-Werle, Natacha
    Schmitt, Claudine
    Brugieres, Laurence
    Vanel, Daniel
    Dupouy, Noelle
    Tabone, Marie-Dominique
    Kalifa, Chantal
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 752 - 761
  • [23] Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma
    Leavey, PJ
    Mantadakis, E
    Maale, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (07) : 483 - 489
  • [24] PLASMA AND CSF METHOTREXATE LEVELS DURING HIGH-DOSE METHOTREXATE CHEMOTHERAPY
    GILCHRIST, NL
    CALDWELL, J
    WATSON, ID
    CUNNINGHAM, D
    FORREST, GJ
    SOUKOP, M
    BRITISH JOURNAL OF CANCER, 1985, 51 (04) : 590 - 590
  • [25] Chemotherapy for osteosarcoma without high-dose methotrexate: A 12-year follow-up on 53 patients
    Tunn, Per-Ulf
    Reichardt, Peter
    ONKOLOGIE, 2007, 30 (05): : 228 - 232
  • [26] Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP)
    O'Kane, Grainne
    Cadoo, Karen Anne
    Walsh, Elaine
    O'Keane, Conor
    O'Toole, Gary
    Dudney, Sean
    Carney, Desmond
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Comparison of Response and Toxicity Between the Neoadjuvant Chemotherapy Using Methotrexate, Doxorubicin, and Cisplatin With or Without Ifosfamide in Osteosarcoma Patients
    Park, M.
    Kang, J. M.
    Ju, H. Y.
    Park, S. Y.
    Kim, J. H.
    Kang, H. G.
    Kwon, M.
    Park, H. J.
    Park, B. K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S315 - S315
  • [28] EXPERIENCE WITH PREOPERATIVE, HIGH-DOSE METHOTREXATE (HDMTX) CONTAINING CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA (OSA)
    HONEGGER, HP
    CSERHATI, MD
    VONHOCHSTETTER, A
    HOFMANN, V
    GROSCURTH, P
    CANCER DRUG DELIVERY, 1986, 3 (01): : 69 - 69
  • [29] Neoadjuvant chemotherapy with high-dose ifosfamide, doxorubicin and cisplatin in nonmetastatic osteosarcoma of the extremity.
    Kudawara, I
    Leguchi, M
    Aoki, Y
    Naka, N
    Araki, N
    Nakanishi, H
    Matsumine, A
    Myoui, A
    Ueda, T
    Yoshikawa, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 827S - 827S
  • [30] NEO-ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE IFOSFAMIDE ADDED TO HIGH-DOSE METHOTREXATE, CISPLATIN AND DOXORUBICIN FOR PATIENTS WITH LOCALIZED OSTEOSARCOMA OF THE EXTREMITY. AN ITALIAN (ISG) AND SCANDINAVIAN (SSG) SARCOMA GROUP STUDY
    Ferrari, Stefano
    Mercuri, Mario
    Longhi, Alessandra
    Picci, Piero
    Setola, Elisabetta
    Capanna, Rodolfo
    Tienghi, Amelia
    Comandone, Alessandro
    Bernini, Gabriella
    Del Prever, Adalberto Brach
    Bacci, Gaetano
    ANNALS OF ONCOLOGY, 2004, 15 : 89 - 89
12345